In a recent report, we demonstrated that changes in methylation of HSPB1, CCND2, TIG1, DPYS, and, MAL, had significant prognostic effects in multivariate Cox models where death from prostate cancer was the study endpoint [11]. This evidence concerns the gene HSPB1 and prostate cancer.